Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare but severely disabling variant within the spectrum of trigeminal autonomic cephalalgia lacking evidence-based treatment.Read More →

CGRP has an important pathophysiological role in cluster headache. Chronic cluster headache patients with insufficient response to other preventive treatments have been receiving individual off-label treatment attempts with CGRP antibodies.Read More →

If you have spent any time on the Cluster Headache Support Group (“CHSG”) Facebook page, then you probably have noticed many comments and questions about Eli Lilly and Company’s (“Lilly”) breakthrough episodic cluster headache treatment called Emgality®. Drawing on our members’ experiences as well as information received from The LillyRead More →